Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jamie Muzzy"'
Autor:
Jamie Muzzy, Dixie Lee Esseltine, Susan F. Slovin, John J. Wright, Barbara MacGregor-Cortelli, Michael D. Stubblefield, Howard I. Scher, David P. Schenkein, Owen A. O'Connor
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 18(5)
Aims Bortezomib (Velcade ® ), a novel proteasome inhibitor, has shown promise in the treatment of malignancies, including multiple myeloma and non-Hodgkin's lymphoma. Several studies have identified neuropathy as a potentially dose-limiting side eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a73032bf446beef063e0ab7d10ab3f8
https://pubmed.ncbi.nlm.nih.gov/16817333
https://pubmed.ncbi.nlm.nih.gov/16817333
Autor:
Owen A. O'Connor, Elizabeth Trehu, David J. Straus, Michael D. Stubblefield, John J. Wright, Jamie Muzzy, Paul A. Hamlin, Otila Dumetrescu, Dixie Lee Esseltine, Julian Adams, Carol S. Portlock, Craig H. Moskowitz, Andrew D. Zelenetz, Barbara MacGregor-Cortelli, David P. Schenkein, Elizabeth Choi
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(4)
Purpose To determine the antitumor activity of the novel proteasome inhibitor bortezomib in patients with indolent and mantle-cell lymphoma (MCL). Patients and Methods Patients with indolent and MCL were eligible. Bortezomib was given at a dose of 1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa5f9c05f6f29978e44456c76709e170
https://pubmed.ncbi.nlm.nih.gov/16130931
https://pubmed.ncbi.nlm.nih.gov/16130931
Autor:
David P. Schenkein, P. Choi, Barbara MacGregor-Cortelli, John Wright, Owen A. O'Connor, D. Straus, Craig H. Moskowitz, Jamie Muzzy, A.D. Zelenetz
Publikováno v:
European Journal of Cancer Supplements. 1:S302
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d29607e7f809641bb69eb752eb3e17f1
https://doi.org/10.1016/s1359-6349(03)91036-6
https://doi.org/10.1016/s1359-6349(03)91036-6
Publikováno v:
Cancer Investigation. Apr2004 Supplement 1, Vol. 22, p35-36. 2p.
Publikováno v:
Cancer Investigation. Apr2004 Supplement 1, Vol. 22, p34-35. 2p.